Non-rotating nano-optic endoscope for 360 degree in vivo imaging
Project Number1R21EB034798-01A1
Former Number1R21EB034798-01
Contact PI/Project LeaderADAMS, DAVID C
Awardee OrganizationMASSACHUSETTS GENERAL HOSPITAL
Description
Abstract Text
Endoscopic optical imaging has the potential for providing critical clinical imaging feedback for a variety of lumi-
nal organs, with notable applications identified in the cardiovascular, pulmonary, and gastrointestinal systems.
A significant drawback of optical endoscopes with side-viewing distal optics is that they must be mechanically
rotated in order to obtain a complete 360 degree picture of the organ being imaged. Arguably, this fact serves
as the biggest impediment to realizing the full potential of endoscopic optical imaging: in addition to the com-
promises one has to make in terms of distal optics, the mechanical rotation of the imaging endoscope entails
serious drawbacks for researchers, clinicians, and commercial enterprises engaged in the imaging modality.
Though difficult to manufacture and subject to far too frequent degradation and outright breakage, perhaps the
biggest issues with mechanically rotated imaging endoscopes are the hard limit mechanical rotation imposes on
image acquisition speed and the difficulty or inability to integrate certain highly valuable functional and contrast
enhancing techniques such as elastography and polarimetry. These facts point to an outdated, stagnant design
that is deeply in need of reinvention. The goal of the proposed research is to develop a novel optical endoscope
that does not need to be rotated to perform 360 degree imaging. The practical advantages of our proposed en-
doscope include increased clinical utility and appeal, widely broadened research possibilities, and the establish-
ment of a clear direction for future optical endoscope research. The aims for this proposal are as follows.
Specific Aim 1 focuses on the design and development of the novel metasurface that will enable passive mod-
ulation of the transmitted beam direction. The metasurface will encode in its nanostructures a large number of
independent holograms that are each individually selective for specific beam parameters and are engineered to
transmit the beam at a unique angle along a complete circle. The metasurface will additionally encode a holo-
graphic lens, eliminating the need for bulk lenses in the distal optical assembly. Characterization of the fabri-
cated metasurface will focus on aspects such as beam profile and spot size, selectivity, and efficiency.
Specific Aim 2 incorporates the metasurface from Aim 1 into a fiber optic endoscope design that utilizes a 360
degree reflecting element for redirecting the holographically-selected beam along a direction nearly perpendic-
ular to the endoscope axis for luminal imaging. Optical characterization will be performed similarly to as in Aim
1, accounting for the combined result of the metasurface and reflector. These tests will be complemented by ex
vivo imaging of airway segments to assess imaging performance.
Public Health Relevance Statement
Screening, diagnosis, and monitoring of disease in internal organs is challenging as tissues are not readily ac-
cessible. Endoscopic optical imaging possesses the greatest potential for addressing this problem, but its util-
ity is significantly impaired by outdated, problematic endoscope design. The successful development of our
metasurface-enhanced endoscope will bring dramatic improvements to the technology while also setting a clear
course for future technological innovations.
NIH Spending Category
No NIH Spending Category available.
Project Terms
3D PrintAccountingAddressAdoptionBiopsyCardiovascular systemClinicalClinical assessmentsComputer softwareDevelopmentDevicesDiagnosisDiagnosticDiseaseDistalElementsEndoscopesEndoscopyEngineeringFeedbackFiber OpticsFoundationsFutureGenerationsGoalsGrowthHeartHolographyImageImpairmentIndividualLasersLightLungMechanicsMinorModificationMonitorMotionNanostructuresOptical Coherence TomographyOpticsOrganPerformancePolymersProliferatingRefractive IndicesResearchResearch PersonnelResolutionRotationScanningSideSortingSpeedSpottingsSurfaceSystemTechniquesTechnologyTestingTimeTissuesUniversitiesValidationWorkX-Ray Computed Tomographybiomedical imagingcancer typeclinical imagingcontrast enhanceddesignelastographyex vivo imagingfabricationgastrointestinal systemhologramimage guidedimaging modalityimaging platformimprovedin vivo imaginginnovationinventionlensmanufacturenanonanofabricationnoveloptical fiberoptical imagingpolarimetrypolymerizationprototyperespiratory imagingscreeningtechnological innovationtechnology developmenttransmission processtwo-photonusability
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
073130411
UEI
FLJ7DQKLL226
Project Start Date
16-September-2024
Project End Date
14-September-2027
Budget Start Date
16-September-2024
Budget End Date
14-September-2027
Project Funding Information for 2024
Total Funding
$647,900
Direct Costs
$400,000
Indirect Costs
$247,900
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$647,900
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R21EB034798-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R21EB034798-01A1
Patents
No Patents information available for 1R21EB034798-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R21EB034798-01A1
Clinical Studies
No Clinical Studies information available for 1R21EB034798-01A1
News and More
Related News Releases
No news release information available for 1R21EB034798-01A1
History
No Historical information available for 1R21EB034798-01A1
Similar Projects
No Similar Projects information available for 1R21EB034798-01A1